Medication info
Empagliflozin 25 mg Tablets

Empagliflozin 25 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Pale yellow, oval-shaped, biconvex film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102033 · Approved 2021.03.04 · Insurance code 693202690

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], adjust or maintain the dose at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
  • cardiovascular disease
View approved original text

This medication is used in conjunction with diet and exercise to assist in blood sugar control for adults with type 2 diabetes. It can also be administered as monotherapy, but is used in combination therapy when sufficient blood sugar control is difficult with other diabetes medications, such as metformin. It improves blood sugar control effects when used in combination with metformin, pioglitazone, sulfonylureas, insulin, or the DPP-4 inhibitor linagliptin. Particularly for patients with cardiovascular disease, it should be used cautiously based on clinical trial information from specialists. This medication effectively improves blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], adjust or maintain the dose at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be administered to certain patients. For example, patients with hypersensitivity to the active ingredient, type 1 diabetes patients, patients with diabetic ketoacidosis, patients with significantly impaired kidney function, and those with genetic issues such as lactose intolerance or galactose intolerance should not take this medication. In patients with slightly impaired kidney function, this medication should be administered cautiously, with regular testing of kidney function while adjusting the dose or discontinuing if necessary. Additionally, this medication is not used in patients with end-stage renal disease or those on dialysis, as its effectiveness cannot be expected. In patients with heart failure, especially those with severe heart failure, experience with this medication is limited, thus caution is required. When used with insulin or other insulin secretagogues such as sulfonylureas, the risk of hypoglycemia may increase, so dose adjustments may be necessary. While taking this medication, side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, decreased fluid volume, increased serum creatinine, etc., may occur, and patients should consult healthcare professionals if symptoms arise. Particularly, serious metabolic disturbances such as ketoacidosis may occur, so if symptoms like nausea, vomiting, abdominal pain, or difficulty breathing appear, patients should immediately visit a healthcare facility for evaluation. Elderly patients or those at risk of fluid loss must be cautious of dehydration or hypotension, and their physical condition should be closely monitored while taking this medication. This medication can increase the risk of dehydration and hypotension when used with other diuretics, and the risk of hypoglycemia may increase when used with insulin secretagogues, thus caution is warranted for combination therapy. Pregnant women should avoid taking this medication, and nursing mothers are advised to discontinue breastfeeding while on this medication. Its safety and effectiveness in pediatric patients under 18 years of age has not been established, so it is not recommended for this age group. There have been no reported specific toxic symptoms from overdose, but in cases of excessive intake, the patient's condition should be closely monitored and appropriate treatment should be provided. This medication should be kept out of reach of children, and transferring it to another container could adversely affect its quality, so caution is advised.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • increased urination
  • urination difficulty
  • interstitial nephritis
  • itching
  • rash
Show 212 more
  • hives
  • angioedema
  • decreased fluid volume
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urinary tract infection
  • urosepsis
  • pyelonephritis
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • retinoschisis
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • dental caries
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyp
  • gingival swelling
  • passage of blood in stools
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • nasopharyngitis
  • orthostatic dizziness
  • sensory loss
  • paresthesia
  • amnesia
  • facial paralysis
  • neuralgia
  • Parkinsonism
  • peripheral neuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • unusual sensation
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormality
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • hematuria
  • hyperactive bladder
  • renal mass
  • urinary retention
  • urinary tract pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • dyslipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • retained sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia
  • acute cholecystitis
  • hepatitis
  • earache
  • orthostatic vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or humidity. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. Proper storage ensures the medication retains its effectiveness over time.

Appearance and packaging

Appearance

Pale yellow, oval-shaped, biconvex film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.